Skip to main content
. 2005 Feb 11;334(1):98–110. doi: 10.1016/j.virol.2005.01.016

Table 3.

Oligonucleotides used for site directed mutagenesis and sequencing

Primer Sequence (5′–3′)a
Forward
K183G+ GCACACGGATGTAggACCCCCAATTTGTG
K183R+ GCACACGGATGTAAggCCCCCAATTTGTG
L65A+ GCCACATTATTGgcTACTGGTTACTACCCG
L65H+ GCCACATTATTGCaaACTGGTTACTACCCG
L79A/T82A+ GTTTAGAAACgcCGCTCTTgCGGGAACTAACTC
L79M/T82M+ GTTTAGAAACaTgGCTCTTAaGGGAACTAACTC
S33G+ GGTGCTAATGTTgGTGCTCCAAGCATTAGC
S33R+ GGTGCTAATGTTcGTGCTCCAAGCATTAGC
S(NotI)+ GCTGTTATAGcGGCCGcGTTTCTGCTGC
S(XbaI)+ GCTTAGGTGTTcTAGAAGATAATTGTGG
T62A+ CGAGTTTATTTAAATGCCgCtTTATTGCTTACTGG
T62S+ CGAGTTTATTTAAATGCCtCtTTATTGCTTACTGG
Y162A+ CCATTTGTCAGTTACCTgcCACTGATTGTAAGC
Y162F+ CCATTTGTCAGTTACCTTcaACTGATTGTAAGC
Y162H+ CCATTTGTCAGTTACCTcACACTGATTGTAAGC
Y162Q+ CCATTTGTCAGTTACCTcAaACTGATTGTAAGC



Reverse
572 TCGCTTTAACACACAAATTGG
BZ25 CCGTCTAGATATGTGGATCTTTTCAACGTC
a

Nucleotides that differ from the S gene sequence of MHV-A59 (GenBank accession no. AY497328) are shown in lower case. Nucleotides that encode amino acid substitutions are underlined.